
Adicet Bio, Inc.
ACETHealthcare|Biotechnology|US
$3.05
+0.13 (+4.45%)
DCF Value
$2.93
Tangible Book / Share
$9.56
Cash / Share
$9.39
Ownership Breakdown
87.8%
Float
9.4M
Shares Outstanding
8.2M
Float Shares
Major Holders (16)
Combined: 93.5%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| RA Capital Healthcare Fund, L.P. | Partnership | 9.90% | 935,486 | Aug 14, 2026 | 13D/G |
| Peter Kolchinsky | HC, IN | 9.90% | 935,486 | Aug 14, 2026 | 13D/G |
| Rajeev Shah | HC, IN | 9.90% | 935,486 | Aug 14, 2026 | 13D/G |
| RA Capital Management, L.P. | IA, PN | 9.90% | 935,486 | Aug 14, 2026 | 13D/G |
| Orbimed Advisors LLC | Investment adviser | 8.80% | 844,787 | Apr 10, 2026 | 13D/G |
| Franklin Advisers, Inc. | IA, CO | 7.70% | 724,138 | Oct 28, 2026 | 13D/G |
| Franklin Templeton, Inc. | HC, CO | 7.70% | 724,138 | Oct 28, 2026 | 13D/G |
| Franklin Resources, Inc. | HC, CO | 6.50% | 626,571 | Jan 29, 2026 | 13D/G |
| Orbimed Capital GP V LLC | Other | 5.90% | 564,147 | Apr 10, 2026 | 13D/G |
| Zedek Lauren Marie | Individual | 5.40% | 502,309 | Oct 23, 2026 | 13D/G |
| Zedek Daniel Clayton | Individual | 5.40% | 502,309 | Oct 23, 2026 | 13D/G |
| Woodline Partners LP | IA, PN | 3.30% | 313,124 | May 15, 2026 | 13D/G |
| Orbimed Capital GP VI LLC | Other | 2.90% | 280,640 | Apr 10, 2026 | 13D/G |
| Kevin Tang | Individual | 0.10% | 6,158 | Feb 17, 2026 | 13D/G |
| Tang Capital Management, LLC | Other | 0.10% | 6,158 | Feb 17, 2026 | 13D/G |
| Tang Capital Partners International, LP | Partnership | 0.10% | 6,158 | Feb 17, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 6,327,483 acquired · 358,029 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Klickstein Lloyd | director, officer: Chief Medical Officer | Aug 5, 2026 | AWARD | 18,300 | $9.16 | $167.6K | Form 4 |
| Schor Chen | director, officer: President & CEO | Jun 19, 2026 | AWARD | 55,000 | $8.10 | $445.5K | Form 4 |
| Aftab Blake | Chief Scientific Officer | Jun 19, 2026 | AWARD | 55,000 | $8.10 | $445.5K | Form 4 |
| DUBIN STEVE | director | Jun 21, 2026 | AWARD | 4,200 | $8.10 | $34.0K | Form 4 |
| Chodakewitz Jeffrey | director | Jun 21, 2026 | AWARD | 4,200 | $8.10 | $34.0K | Form 4 |
| Grissinger Michael | director | Jun 21, 2026 | AWARD | 4,200 | $8.10 | $34.0K | Form 4 |
| Sinclair Andrew | director | Jun 21, 2026 | AWARD | 4,200 | $8.10 | $34.0K | Form 4 |
| Peng Katie | director | Jun 21, 2026 | AWARD | 4,200 | $8.10 | $34.0K | Form 4 |
| Klickstein Lloyd | director | Jun 21, 2026 | AWARD | 4,200 | $8.10 | $34.0K | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | Apr 27, 2026 | J | 250,000 | $0.00 | $25.00 | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | Apr 27, 2026 | DISPOSED | 250,000 | $0.00 | $25.00 | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | Feb 20, 2026 | BUY | 74,751 | $7.27 | $543.4K | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | Feb 19, 2026 | BUY | 74,268 | $7.21 | $535.5K | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | Feb 18, 2026 | BUY | 74,577 | $7.04 | $525.0K | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | Feb 17, 2026 | OTHER | 0 | — | — | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | Feb 17, 2026 | OTHER | 1,152,833 | $0.00 | $115.28 | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Apr 7, 2026 | SELL | 29,319 | $6.53 | $191.5K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Apr 7, 2026 | SELL | 2,400 | $6.38 | $15.3K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Apr 8, 2026 | SELL | 32,523 | $6.29 | $204.6K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Apr 8, 2026 | SELL | 40,416 | $6.52 | $263.5K | Form 4 |
| Harvey Brian Nicholas | Chief Financial Officer | Mar 25, 2026 | AWARD | 43,361 | $6.81 | $295.3K | Form 4 |
| Schor Chen | director, officer: President & CEO | Mar 25, 2026 | AWARD | 468,555 | $6.81 | $3.2M | Form 4 |
| Maltzman Julia D. | Chief Medical Officer | Mar 25, 2026 | AWARD | 72,555 | $6.81 | $494.1K | Form 4 |
| Healey Don | Chief Technology Officer | Mar 25, 2026 | AWARD | 43,361 | $6.81 | $295.3K | Form 4 |
| Aftab Blake | Chief Scientific Officer | Mar 25, 2026 | AWARD | 72,555 | $6.81 | $494.1K | Form 4 |
| Aftab Blake | Chief Scientific Officer | Jan 24, 2026 | TAX W/H | 535 | $8.44 | $4.5K | Form 4 |
| Healey Don | Chief Technology Officer | Jan 24, 2026 | TAX W/H | 535 | $8.44 | $4.5K | Form 4 |
| Schor Chen | director, officer: President & CEO | Jan 24, 2026 | TAX W/H | 1,755 | $8.44 | $14.8K | Form 4 |
| Harvey Brian Nicholas | Chief Financial Officer | Jan 24, 2026 | TAX W/H | 546 | $8.44 | $4.6K | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Oct 8, 2025 | BUY | 1,500,000 | $1.00 | $1.5M | Form 4 |
| ORBIMED ADVISORS LLC | 10 percent owner | Oct 8, 2025 | BUY | 3,500,000 | $1.00 | $3.5M | Form 4 |
| Klickstein Lloyd | director | Jun 11, 2025 | AWARD | 5,900 | — | — | Form 4 |
| Klickstein Lloyd | director | Jun 11, 2025 | AWARD | 26,400 | $0.78 | $20.6K | Form 4 |
| Chodakewitz Jeffrey | director | Jun 11, 2025 | AWARD | 26,400 | $0.78 | $20.6K | Form 4 |
| Chodakewitz Jeffrey | director | Jun 11, 2025 | AWARD | 5,900 | — | — | Form 4 |
| DUBIN STEVE | director | Jun 11, 2025 | AWARD | 26,400 | $0.78 | $20.6K | Form 4 |
| DUBIN STEVE | director | Jun 11, 2025 | AWARD | 5,900 | — | — | Form 4 |
| Peng Katie | director | Jun 11, 2025 | AWARD | 26,400 | $0.78 | $20.6K | Form 4 |
| Peng Katie | director | Jun 11, 2025 | AWARD | 5,900 | — | — | Form 4 |
| Sinclair Andrew | director | Jun 11, 2025 | AWARD | 26,400 | $0.78 | $20.6K | Form 4 |
| Sinclair Andrew | director | Jun 11, 2025 | AWARD | 5,900 | — | — | Form 4 |
| Grissinger Michael | director | Apr 17, 2025 | AWARD | 70,200 | $0.53 | $36.9K | Form 4 |
| Grissinger Michael | Apr 17, 2025 | OTHER | 0 | — | — | Form 4 | |
| Aftab Blake | Chief Scientific Officer | Jan 31, 2025 | AWARD | 275,000 | $0.89 | $243.4K | Form 4 |
| Schor Chen | director, officer: President & CEO | Jan 31, 2025 | AWARD | 763,829 | $0.89 | $676.0K | Form 4 |
| Healey Don | Chief Technology Officer | Jan 31, 2025 | AWARD | 275,000 | $0.89 | $243.4K | Form 4 |
| Maltzman Julia D. | Chief Medical Officer | Jan 31, 2025 | AWARD | 750,000 | $0.89 | $663.8K | Form 4 |
| Harvey Brian Nicholas | Chief Financial Officer | Jan 31, 2025 | AWARD | 324,040 | $0.89 | $286.8K | Form 4 |
| Schor Chen | director, officer: President & CEO | Jan 24, 2025 | TAX W/H | 28,101 | $0.92 | $25.9K | Form 4 |
| Healey Don | Chief Technology Officer | Jan 24, 2025 | TAX W/H | 8,560 | $0.92 | $7.9K | Form 4 |
| Aftab Blake | Chief Scientific Officer | Jan 24, 2025 | TAX W/H | 6,270 | $0.92 | $5.8K | Form 4 |
| Harvey Brian Nicholas | Chief Financial Officer | Jan 24, 2025 | TAX W/H | 8,752 | $0.92 | $8.1K | Form 4 |
| Maltzman Julia D. | Jan 13, 2025 | OTHER | 0 | — | — | Form 4 | |
| Sinclair Andrew | director | Aug 21, 2024 | AWARD | 28,828 | $15.75 | $454.0K | Form 4 |
| Sinclair Andrew | director | Aug 21, 2024 | AWARD | 26,400 | $5.20 | $137.1K | Form 4 |
| Sinclair Andrew | director | Aug 21, 2024 | AWARD | 18,500 | $15.93 | $294.7K | Form 4 |
| Sinclair Andrew | director | Aug 21, 2024 | AWARD | 18,500 | $11.49 | $212.6K | Form 4 |
| Sinclair Andrew | director | Aug 21, 2024 | AWARD | 8,172 | $15.93 | $130.2K | Form 4 |
| Sinclair Andrew | director | Aug 21, 2024 | DISPOSED | 26,400 | $2.14 | $56.5K | Form 4 |
| GORDON CARL L | director, 10 percent owner: | Aug 21, 2024 | AWARD | 30,000 | $16.11 | $483.3K | Form 4 |
| GORDON CARL L | director, 10 percent owner: | Aug 21, 2024 | AWARD | 26,400 | $5.20 | $137.1K | Form 4 |
| GORDON CARL L | director, 10 percent owner: | Aug 21, 2024 | AWARD | 18,500 | $15.93 | $294.7K | Form 4 |
| GORDON CARL L | director, 10 percent owner: | Aug 21, 2024 | AWARD | 18,500 | $11.49 | $212.6K | Form 4 |
| GORDON CARL L | director, 10 percent owner: | Aug 21, 2024 | DISPOSED | 26,400 | $2.14 | $56.5K | Form 4 |
| Peng Katie | director | Aug 21, 2024 | AWARD | 70,200 | $3.38 | $237.3K | Form 4 |
| Peng Katie | director | Aug 21, 2024 | DISPOSED | 70,200 | $2.14 | $150.2K | Form 4 |
| Chodakewitz Jeffrey | director | Aug 21, 2024 | AWARD | 30,000 | $16.11 | $483.3K | Form 4 |
| Chodakewitz Jeffrey | director | Aug 21, 2024 | AWARD | 26,400 | $5.20 | $137.1K | Form 4 |
| Chodakewitz Jeffrey | director | Aug 21, 2024 | AWARD | 18,500 | $15.93 | $294.7K | Form 4 |
| Chodakewitz Jeffrey | director | Aug 21, 2024 | AWARD | 18,500 | $11.49 | $212.6K | Form 4 |
| Chodakewitz Jeffrey | director | Aug 21, 2024 | DISPOSED | 26,400 | $2.14 | $56.5K | Form 4 |
| DUBIN STEVE | director | Aug 21, 2024 | AWARD | 30,000 | $16.11 | $483.3K | Form 4 |
| DUBIN STEVE | director | Aug 21, 2024 | AWARD | 26,400 | $5.20 | $137.1K | Form 4 |
| DUBIN STEVE | director | Aug 21, 2024 | AWARD | 18,500 | $11.49 | $212.6K | Form 4 |
| DUBIN STEVE | director | Aug 21, 2024 | AWARD | 18,500 | $15.93 | $294.7K | Form 4 |
| DUBIN STEVE | director | Aug 21, 2024 | DISPOSED | 26,400 | $2.14 | $56.5K | Form 4 |
| Kauffman Michael | director | Aug 21, 2024 | AWARD | 37,000 | $9.39 | $347.4K | Form 4 |
| Kauffman Michael | director | Aug 21, 2024 | AWARD | 26,400 | $5.20 | $137.1K | Form 4 |
| Kauffman Michael | director | Aug 21, 2024 | AWARD | 18,500 | $11.49 | $212.6K | Form 4 |
| Kauffman Michael | director | Aug 21, 2024 | DISPOSED | 26,400 | $2.14 | $56.5K | Form 4 |
| Jakobovits Aya | director | Aug 21, 2024 | AWARD | 30,000 | $16.11 | $483.3K | Form 4 |
| Jakobovits Aya | director | Aug 21, 2024 | AWARD | 26,400 | $5.20 | $137.1K | Form 4 |
| Jakobovits Aya | director | Aug 21, 2024 | AWARD | 18,500 | $15.93 | $294.7K | Form 4 |
| Jakobovits Aya | director | Aug 21, 2024 | AWARD | 18,500 | $11.49 | $212.6K | Form 4 |
| Jakobovits Aya | director | Aug 21, 2024 | DISPOSED | 26,400 | $2.14 | $56.5K | Form 4 |
| Klickstein Lloyd | director | Aug 19, 2024 | AWARD | 70,200 | $1.55 | $108.8K | Form 4 |
| Klickstein Lloyd | director | Aug 19, 2024 | DISPOSED | 0 | — | — | Form 4 |
| Klickstein Lloyd | director | Aug 19, 2024 | DISPOSED | 80,000 | $2.14 | $171.2K | Form 4 |
| Aftab Blake | Chief Scientific Officer | Jun 5, 2024 | AWARD | 336,911 | $2.53 | $852.4K | Form 4 |
| Galimi Francesco | SVP & Chief Medical Officer | Jun 5, 2024 | AWARD | 375,077 | $2.53 | $948.9K | Form 4 |
| Harvey Brian Nicholas | Chief Financial Officer | Jun 5, 2024 | AWARD | 374,829 | $2.53 | $948.3K | Form 4 |
| Healey Don | Chief Technology Officer | Jun 5, 2024 | AWARD | 271,595 | $2.53 | $687.1K | Form 4 |
| Schor Chen | director, officer: President & CEO | Jun 5, 2024 | AWARD | 1,770,427 | $2.53 | $4.5M | Form 4 |
| GORDON CARL L | director, 10 percent owner: | Jun 5, 2024 | AWARD | 26,400 | $1.44 | $38.0K | Form 4 |
| GORDON CARL L | director, 10 percent owner: | Jun 5, 2024 | AWARD | 5,900 | — | — | Form 4 |
| Chodakewitz Jeffrey | director | Jun 5, 2024 | AWARD | 26,400 | $1.44 | $38.0K | Form 4 |
| Chodakewitz Jeffrey | director | Jun 5, 2024 | AWARD | 5,900 | — | — | Form 4 |
| Jakobovits Aya | director | Jun 5, 2024 | AWARD | 26,400 | $1.44 | $38.0K | Form 4 |
| Jakobovits Aya | director | Jun 5, 2024 | AWARD | 5,900 | — | — | Form 4 |
| DUBIN STEVE | director | Jun 5, 2024 | AWARD | 26,400 | $1.44 | $38.0K | Form 4 |